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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: A long-term retrospective study was conducted to assess the risk factors
of renal transplant graft failure focusing on the effects of gender of both the donor and the
recipient.
Methods: Medical records of primary renal transplantation performed in a single transplant
hospital were reviewed. Cases of ABO incompatibility, positive cross-matches, or multiple or-
gan transplants were excluded. A total of 766 patient records were reviewed, and variables
were analyzed with KaplaneMeier survival curves and Cox regression to determine the inde-
pendent factors associated with graft survival.
Results: The overall 5-year graft and patient survival rates were 84.7% and 92.2%, respectively.
Univariate analysis showed significantly poorer prognosis in male patients and in those with
acute rejection, delayed function, or more mismatches in human lymphocyte antigens. Multi-
variate analysis with step-wise regression identified three independent prognostic factors for
poor graft survival (male gender, acute rejection, and delayed function). The 5-year graft
survival rates for female and male patients were 87.9% and 81.3%, respectively. The risk ratio
of graft failure for male renal transplant recipients was 1.3732, when compared with that for
female patients. The risk ratios for those with acute rejection and delayed function were
1.8330 and 1.5422, respectively.
Conclusion: Male gender, in addition to acute rejection and delayed function, was found to be
an independent prognostic factor for poor renal transplant survival in this long-term retrospec-
tive study.
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Renal transplantation has been a preferable treatment
method for patients with end-stage renal disease. It is also
associated with improved patient survival and quality of life
when compared with dialysis. Although numerous reports
on survival of kidney grafts and their recipients have been
published, the factors influencing long-term survival of the
renal graft is still a matter of considerable debate. More
recent studies have reported that patients with a greater
number of human leukocyte antigen (HLA) mismatches,
the presence of acute rejection, and delayed graft
function are at higher risks of graft failure. The role of
other factors including age and gender of the donor and the
recipient, donor type, and hepatitis profiles are currently
unknown.1e3
In 2002, based on the data from the Collaborative
Transplant Study, Zeier et al4 reported that the donor
gendereassociated risk ratio for graft loss was 1.15 in fe-
male recipients and 1.22 in male recipients, and that the
graft survival was worse when the donor was female and
the recipient was male. However, the independent effects
of recipient gender on renal transplant survival were not
well documented. Therefore, we conducted a long-term
retrospective study to assess the risk factors of renal
transplant graft failure focusing on the effects of both
donor and recipient genders. Stepwise regression pro-
cedures were performed to select a multivariate regression
model of independent prognostic factors with maximal
corresponding likelihood ratio statistic.Materials and methods
Study population and design
A retrospective study was conducted to assess risk factors
of renal transplant graft failure. Medical records of primary
renal transplantation performed in a single hospital be-
tween April 1988 and December 2009 were reviewed.
Patients with ABO incompatibility, positive cross-matches,
multiple organ transplants, and second transplants were
excluded.
Immunosuppressive therapy
Immunosuppressive therapy for all the patients were regi-
mens based on a calcineurin inhibitor, either cyclosporine
or tacrolimus, an antiproliferative agent, and corticoste-
roids. The antiproliferative agent could be mycophenolate
mofetil, mycophenolate sodium, or azathioprine. Anti-
lymphocyte antibodies were not used for induction therapy
but solely for rescue of refractory acute rejection.
The dosage of calcineurin inhibitors was adjusted to the
target trough levels of 200e400 ng/mL for cyclosporine and
8e16 ng/mL for tacrolimus. The target blood levels at 12
months were 100e200 ng/mL for cyclosporine and 5e8 ng/
mL for tacrolimus. Mycophenolate mofetil or mycopheno-
late sodium was prescribed at initial doses of 1e2 g/day
and 720e1440 mg/day, respectively. Azathioprine was used
in some early cases at doses between 50 and 100 mg/day.The white blood cell counts were controlled to be between
4000 and 6000/mm3 unless intolerance developed or the
maximum dose was reached. Methylprednisolone (500 mg)
was initially used once before reperfusion. Prednisolone, at
a dose of 2.5e5 mg/day for 12 months and thereafter, was
used and could be tapered down or even discontinued if
significant side effects occurred.
Outcome measurement
Delayed graft function was defined as persistent oliguria
(<400 mL/24 hours) or the requirement for dialysis during
the 1st week after transplantation. All patients with sus-
picious episodes of acute rejection (persistent oliguria for
more than 7 days after transplantation or elevation of
creatinine level by more than 30% of baseline levels) un-
derwent allograft renal biopsy to pursue the pathological
diagnosis. An episode of acute rejection was primarily
treated with methylprednisolone pulse therapy, and anti-
lymphocyte antibodies could be used to treat those re-
fractory to steroid therapy. Graft failure was defined as
return to chronic dialysis for more than 30 days, retrans-
plantation, graft removal, or death of the recipient with
functional kidney, whichever came first. Furthermore, the
status patients lost to follow-up would be considered based
on their last visit.
Statistical analysis
The NCSS 8 software (NCSS, LLC, Kaysville, UT) was used for
statistical analysis. Values were reported as arithmetic
means  standard deviations. Unpaired two-tailed t tests
were used for normally distributed continuous variables;
and the Chi-square test or Fischer exact test was used for
categorical variables. A p value of 0.05 was adopted as the
level of significance. Graft survival rates were estimated
using the KaplaneMeier method. Univariate analysis model
with log-rank test was used to examine significance of the
prognostic factors. The prognostic significance of the
recipient’s age, donor’s age, and HLA mismatch for graft
survival was determined using Cox regression model. The
factors that were statistically significant in the univariate
analysis were then analyzed using a multivariate regression
model to determine the independent effect of each factor.
Results
Patient characteristics
We performed 852 renal transplants in a single medical
center between April 1988 and December 2009. A total of
766 patients were recruited in this study, including 364
male and 402 female patients. We excluded 20 cases with
ABO incompatibility, six with positive cross-matches, 27
with multiple organ transplants, and 33 with second
transplants.
On average, the male patients (40.0  12.5) and female
patients (41.9  11.7) were of similar ages when undergo-
ing transplant. Although data could be missing in our early
cases, more male recipients received renal graft from
Genders in renal transplant survival 785female donors (50.2%, 114/227) than the female patients
(40.5%, 122/301; p < 0.05, Chi-square test). The female
patients had a lower body weight (50.6  9.1 kg) than the
males (61.7  13.3 kg; pZ 0.003), but received grafts from
those with higher body weights (65.2  13.7 vs. 61.9  13.9,
p < 0.001). The donor/recipient weight ratio between fe-
male and male patients was significantly different. There
were no significant differences between male and female
recipients in average donor age, the number of HLA mis-
matches, and numbers with positive hepatitis B or hepatitis
C. The males had a higher incidence of delayed function
(24.9%, 89/358) than females (16.8%, 66/392; p < 0.05),
but the frequency of acute rejection was not significantly
different between male (33.9%, 123/363) and female re-
cipients (29.9%, 119/398). The average follow-up duration
was 79.8  58.3 months for male and 78.2  49.7 months
for female patients. Baseline characteristics for the male
and female groups are summarized in Table 1.
Prognostic factors for graft survival
Univariate analysis of the prognostic factors (Table 2)
revealed that female recipients had a significantly longer
5-year graft survival than male recipients (87.9% vs. 81.3%;
p < 0.05). In addition, we also identified several significant
predictive factors for graft failure, including acute rejec-
tion (p < 0.05), delayed function (p < 0.05), and the
number of HLA mismatches (risk ratio: 1.1374 per
mismatch; p < 0.05). The difference in the 5-year graft
survival rate in patients who received transplants from
deceased donors (84.5%) and living donors (85.8%) did not
reach statistical significance. The 5-year graft survival of
renal transplants from male donors (85.3%) was similar to
those from female donors (84.5%). Besides, grafts of higher
body weight did not ensure a better graft survival; donor
weight, recipient weight, and donor-to-recipient weight
ratio were not significant factors for graft survival.Table 1 Demographic profiles of the male and female groups h
Male group
Characteristicsa N Z 364
Age at transplantation (years) 40.0  12.5
Donor age (years) 41.7  12.7
Donor type (deceased) 67.6% (246/364)
Donor gender (female) 50.2% (115/227)
HLA mismatch 2.93  1.41
HBsAg (þ) 16.2% (54/333)
Anti-HCV (þ) 16.5% (55/333)
De novo tacrolimus 42.5% (128/301)
Acute rejection 33.9% (123/363)
Delayed function 24.9% (89/358)
Recipient weight (kg) 61.7  13.3
Donor weight (kg) 61.9  13.9
Donor-to-recipient weight ratio 1.11  0.66
Follow-up period (mo) (range) 79.8  58.3 (1e28
Anti-HCV Z antihepatitis C antibody; HbsAg Z hepatitis B surface an
*The two-tailed Fisher exact test was used for categorical variables;
a Donor data would be missing in early cases.Recipients with positive hepatitis B surface antigen (HBsAg)
had a comparable 5-year graft survival (83.9%) to those with
negative HBsAg (84.7%); in addition, antihepatitis C anti-
body positivity did not appear to influence survival (positive
85.2% vs. negative 84.4%). As for immunosuppressive ther-
apy, 44.4% (276/622) of the patients were confirmed to
have received de novo tacrolimus-based therapy, and 55.6%
(346/622) received cyclosporine-based therapy. However,
tacrolimus was not a significant factor associated with graft
survival in this study.
Results of the multivariate analysis were shown in
Table 3, which identified three prognostic factors for graft
failuredmale patients (risk ratio: 1.3732, p < 0.05),
delayed function (risk ratio: 1.5422, p < 0.05), and acute
rejection (risk ratio: 1.8330, p < 0.05).
Gender difference in donorerecipient
combinations and the risk of graft loss
KaplaneMeier estimates of graft survival, as illustrated in
Fig. 1, showed that female patients had a significantly
better 5-year graft survival than male patients. To evaluate
whether there was an increased risk of graft loss due to an
interaction between donor gender and recipient gender, a
survival analysis was performed to evaluate the effect of
donor gender on male and female patients.
There were 179 male donor-to-female-recipient trans-
plants, and 113, 114, 122 male-to-male, female-to-male,
and female-to-female combinations, respectively. The
5-year survival rate was relatively higher in the male-to-
female group (87.9%), followed by the female-to-female
group (85.5%), male-to-male group (83.9%), and female-to-
male group (83.2%), which are shown in Fig. 2. The trans-
plants from male donors tended to have better graft
survival. However, the small numbers in each subgroup
might compromise the statistical significance. In female
recipients, transplants from male and female donorsaving kidney transplants between 1988 and 2009.
Female group p*
N Z 402
41.9  11.7 NS
41.6  12.7 NS
70.1% (282/402) NS
40.5% (122/301) 0.027
2.79  1.44 NS
11.8% (42/355) NS
16.3% (58/355) NS
46.1% (148/321) NS
29.9% (119/398) NS
16.8% (66/392) 0.008
50.6  9.1 0.003
65.2  13.7 <0.001
1.32  0.37 0.002
4) 78.2  49.7 (1e251) NS
tigen; HLA Z human leukocyte antigen; NS Z not significant.
two-tailed unpaired t test was used for continuous variables.
Table 2 Univariate analysis of prognostic factors for kidney transplant survival.
Log-rank test Category Number of patients 5-year graft survival p
Recipient gender Male 364 81.3% 0.008
Female 402 87.9%
Donor gender Male 292 85.3% NS
Female 236 84.5%
Donor type Deceased 528 84.5% NS
Living 238 85.8%
HbsAg Positive 96 83.9% NS
Negative 592 84.7%
Anti-HCV (þ) Positive 113 85.2% NS
Negative 575 84.4%
De novo tacrolimus Yes 276 85.4% NS
No 346 82.9%
Acute rejection Yes 242 76.1% <0.001
No 519 88.9%
Delayed function Yes 155 79.2% <0.001
No 595 86.4%
Cox’s regression Regression coefficient Standard error Risk ratio p
Age at transplantation 0.0039 0.0058 0.9961 NS
Recipient weight 0.0077 0.0077 1.0078 NS
Donor weight 0.0008 0.0128 1.0008 NS
Donor-to-recipient weight ratio 0.4653 0.5207 0.6279 NS
Donor age 0.0147 0.0084 1.0148 NS
HLA mismatch 0.1287 0.0521 1.1374 0.0150
Anti-HCV Z antihepatitis C antibody; HbsAg Z hepatitis B surface antigen; HLA Z human leukocyte antigen; NS Z not significant.
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vival. The log-rank test showed that transplants from male
and female donors had similar survival rates in male pa-
tients. The influence of the donor gender on graft survival
might be diminished by the strong effect of the recipient
gender.
Discussion
The role of gender in solid organ transplantations such as
lung, heart, and liver has been extensively studied, and the
data from some investigations suggested that female do-
nors to male recipients could be a risk factor for graft
loss.5e7 As for renal transplantation, limited reports also
implied inferior long-term graft survival when female
kidneys are transplanted into male patients,4,8 yet the in-
dependent effect of recipient gender on renal transplant
survival needs to be documented.
Previous studies examining donorerecipient size
mismatch debated a graft survival advantage for kidneyTable 3 Multivariate Cox regression analysis of the fac-
tors with statistical significance in the univariate analysis.
Cox’s regression Regression
coefficient
Standard
error
Risk
ratio
p
Male gender 0.3171 0.1427 1.3732 0.026
Acute rejection 0.6059 0.1406 1.8330 <0.001
Delayed function 0.4332 0.1503 1.5422 0.004recipients who receive larger organs in relation to their own
body size.9,10 In this study, the body weights of donors for
female patients were heavier than recipients, yet a higher
body weight ratio between the donor and the recipient did
not reflect a better graft survival. In addition, the donor
gender did not have a significant influence on the graft
survival in our data, although a higher rate of kidney graft
loss from female donor had been documented with possible
lower donor body weight and fewer nephrons from female
kidneys.11Figure 1 KaplaneMeier survival curves showing the differ-
ence between male and female recipients (p < 0.05).
Figure 2 KaplaneMeier plots detailing the relative differ-
ence in graft survival among four donorerecipient gender
combinations. The graft survival curves for female recipients
receiving transplants from either male or female donors
showed no significant difference (p > 0.05), and so did those
for male recipients (p > 0.05).
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prognostic factor for poor renal transplant survival in this
long-term retrospective study. By analyzing data on 73,477
primary renal transplants collected in the US Renal Data
System database, Meier-Kriesche et al12 reported that fe-
males had a 10% increased odds of acute rejection, but
conversely a 10% lower risk of graft loss secondary to
chronic allograft failure. Protection afforded by hormones
and complex immunological processes in women might
explain their better long-term prognosis.12,13 Reviews also
suggested that female kidney, perhaps related to sensiti-
zation after pregnancy, is less likely to develop chronic
graft rejection.14 Our study supported the hypothesis that
the grafts from female donors to male patients have a worst
prognosis, although the difference between the gender
combinations did not reach statistical significance with
limited number in each combination.
As expected, regardless of gender, our data reported
acute rejection as a negative independent risk factor for
renal graft loss, and the risk of poor graft outcome with the
incidence of delayed graft function and the increase in the
number of HLA mismatches, which were compatible with
previous studies.15e17 Our data revealed that female pa-
tients tend to have less number of HLA mismatches and less
acute rejection, but the difference was not significant. In
addition, the female patients tend to encounter less
delayed graft function after renal transplantation. The
correlation may have partial roles, but the difference in
gender continued to be an independent factor determining
in graft survival. However, we had reported that changes in
creatinine level after transplantation could be one of the
most important prognostic factors for graft survival.18
The increase in the number of kidneys transplanted has
led to concern about whether the organ pool expansion has
affected patient and graft survival.19,20 However, renal
transplants from deceased donors, in this study, did not
have a significantly worse outcome than those from living
donors, and no significant difference was noted in donors ofadvanced age. There could be other factors, in addition to
the biological effects, associated with the worse prognosis
of male patients. Noncompliance is one of the most
important problems in modern medicine, and it could be
encountered in nearly half of the patients with acute
rejection after transplantation, which may lead to late
rejection, organ loss, and recipient death in kidney trans-
plant recipients.21,22 Using biographical questionnaires, it
was documented that women had better immunosuppres-
sant compliance than men.23,24 In addition, women com-
plied with more regular follow-up visits, less alcohol use
(habit change), and more frequent antineoplastic prophy-
lactic examinations.25 In general, women appear to have
better compliance than men after transplantation, and
show more concern with regard to protecting graft
function.
This study was limited by its retrospective nature;
however, the single-center design minimized center-
specific effects such as differences in immunosuppression
protocols and perioperative and postoperative care. In
conclusion, the results of this study showed that recipient
gender, in addition to acute rejection and delayed graft
function, was an independent risk factor associated with
renal graft survival. Further studies on gender differences
in de novo antibody, recurrent diseases, and compliance
might help to figure out why gender played an important
role in renal transplant graft survival in Taiwan.
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